PDCD1 and neoplasm: Moreover, the combination of the PC7A nanovaccine and the anti-PD-1 antibody showed great synergy and was associated with the complete inhibition of tumour growth and improved survival in animal tumour models, suggesting anti-tumour memory generation [583].